ArticleInternal medicine (Tokyo, Japan)2025
Efficacy and Safety of Rituximab plus Modified EPOCH (Etoposide, Vincristine, Doxorubicin, Carboplatin, and Prednisolone) for Transplant-ineligible Relapsed/Refractory Diffuse Large B-cell Lymphoma.
Eriko Fujioka et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.